Abram Brown is a Senior Editor at Forbes. He writes about social media, creators, and digital culture, with a focus on technology, artificial intelligence, and enterprise tech. Abram's insights and expertise have also been featured in RealClearMarkets, The Messenger, Knowledia, and The Information.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Abram's coverage encompasses a wide range of topics related to technology, social media, and artificial intelligence. He often delves into the legal and regulatory aspects of these subjects, as well as government announcements and investment analysis.
Given Abram's focus on content & publishing and big tech, he may be particularly interested in pitches that offer expert insights or data-driven analysis on emerging trends in these industries. Topics such as the impact of AI on content creation, ethical considerations around social media algorithms, or the implications of government regulations on big tech companies could align with his areas of interest.
As Abram does not have a specific geographic focus but rather covers international issues within the realm of technology and big tech-related policies and developments.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Julia Hornstein, Abram Brown
Welcome, Weekenders! In this newsletter:• The Big Read: Why Trump officials and VCs love a nuclear power startup’s brute-force approach• Biotech: The case of the disappearing embryo startups• Plus, Recommendations—our weekly pop culture picks: “Are We Doomed?” “Steve Jobs in Exile” and “Lord of ...
It may feel like AI has seeped deep into our lives, but compared to the world within “Certainty,” a new dystopian novel by best-selling author John Twelve Hawks, we’re practically in the Flintstones era. In Twelve Hawks’ realm, self-driving tractor-trailers dominate the highways. Parents ...
By: Abram Brown
Demand for knockoff versions of retatrutide, a peptide-based drug being developed by Eli Lilly, has skyrocketed lately, propelling a gray market that likely exceeds $100 million in annual sales, according to an estimate prepared by The Information that examined many of the market’s biggest suppliers.Retatrutide, or reta as it is commonly called, has become popular among the tech elite, who
Welcome, Weekenders! In this newsletter:• The Big Read: Pickleball is the past—the tech elite is obsessed with padel.• Plus, an Americana-themed batch of Recommendations—our weekly pop culture picks: “The Americans,” “East of Eden,” “High Desert Daydream,” “Lonesome Dove,” USA vs. Belgium, and “ ...
By: Abram Brown
Utter kitchen chaos unfolded when Brynn Putnam and I got together a week or so ago and she suggested a round of “Chop, Chop,” a collaborative restaurant simulation game created by her startup, Board. Even under her close supervision, I still nearly burned the grilled cheese—then left the tomato ...
• The Big Read: Silicon Valley looks to a new biotech frontier—Montana• Garry Tan’s political dreams require this 32-Year-Old’s ‘grunt’ force• Plus, Recommendations—our weekly pop culture picks: “Dead Rabbit,” “The Amateur” and “The Drama”Here’s a thought that would’ve seemed startling not long ...
• The Big Read: AI promises to cure cancer. Scientists feel existential dread• The new robotics ‘arms race’: Who can do the craziest hype video?• Plus, Recommendations—our weekly pop culture picks: “Dan Taberski’s Manifesto,” “A Tender Age” and “The End of Oak Street” With surprising swiftness, ...
